✦ LIBER ✦

What Is the Future of Oncology? National Cancer Institute Initiatives to Improve Research, Development, and Implementation in Cancer Prevention and Treatment

✍ Scribed by Ernest Hawk; Jaye L. Viner

Book ID: 114474011
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 272 KB
Volume: 33
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2006.10.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Merging of the National Cancer Institute

Merging of the National Cancer Institute–funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group

✍ R. Aplenc; B. T. Fisher; Y. S. Huang; Y. Li; T. A. Alonzo; R. B. Gerbing; M. Hal 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Carcinogens and Anticarcinogens in the H

Carcinogens and Anticarcinogens in the Human Diet: A Comparison of Naturally Occurring and Synthetic Substances.by Committee on Comparative Toxicity of Naturally Occurring Carcinogens; Board on Environmental Studies and Toxicology; Commission on Life Sciences; National Research Council;Dietary Phytochemicals in Cancer Prevention and Treatment.by American Institute for Cancer Research

✍ Review by: George C. Williams 📂 Article 📅 1997 🏛 University of Chicago Press 🌐 English ⚖ 351 KB

Alemtuzumab in Combination With Methylpr

Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial

✍ Pettitt, A. R.; Jackson, R.; Carruthers, S.; Dodd, J.; Dodd, S.; Oates, M.; John 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 246 KB

Adherence of non-pharmaceutically sponso

Adherence of non-pharmaceutically sponsored oncology trial protocols to the International Conference on Harmonization (ICH) guidelines in an academic institution outside the ICH jurisdictions and the impact of IRB implementation on this adherence

✍ Zeeneldin, Ahmed A. 📂 Article 📅 2013 🏛 National Cancer Institute - Egypt 🌐 English ⚖ 323 KB

Supplement 1: AHCPR Smoking Cessation Gu

Supplement 1: AHCPR Smoking Cessation Guideline: Its Goals and Impact: Proceedings of a National United States Conference Convened by the Society for Research on Nicotine and Tobacco, Sponsored by the Robert Wood Johnson Foundation, Centers for Disease Control and Prevention Office on Smoking and Health, National Cancer Institute, and Agency for Health Care Policy and Research. Washington, DC, 17-18 September 1996 || Implementing Smoking Cessation Protocols in Medical and Dental Practices

✍ Stuart J. Cohen 📂 Article 📅 1997 🏛 BMJ Publishing Group 🌐 English ⚖ 615 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB